Mitokinin Patents – Insights & Stats

Mitokinin has a total of 60 patents globally, out of which 15 have been granted. Of these 60 patents, more than 86% patents are active. Australia is where Mitokinin has filed the maximum number of patents, followed by the United States of America. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Mitokinin.

Mitokinin was founded in 2017. Mitokinin is a company that works in the healthcare sector with a focus on biotechnology. The company creates PINK1 targeted medicines to treat mitochondrial and neurodegenerative illnesses.

Do read about some of the most popular patents of Mitokinin which have been covered by us in this article and also you can find Mitokinin patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Mitokinin patent portfolio.

How many patents do the Founder and CEO of Mitokinin have?

The Founder Kevan Shokat have 15 patents, Daniel De Roulet (Also CEO) have 6 patents, Nicholas Hertz have 0 patent.

How many patents does Mitokinin have?

Mitokinin has a total of 60 patents globally. These patents belong to 10 unique patent families. Out of 60 patents, 52 patents are active.

How Many Patents did Mitokinin File Every Year?

Mitokinin Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantMitokinin Applications FiledMitokinin Patents Granted
202311
2022106
2021163
2020123
201911
201871
20171
20158
20144

How many Mitokinin patents are Alive/Dead?

Worldwide Patents

Mitokinin Patent Portfolio

How Many Patents did Mitokinin File in Different Countries?

Mitokinin Worldwide Patent Filing

Countries in which Mitokinin Filed Patents

CountryPatent
Australia9
United States Of America7
Canada6
Europe6
Mexico3
Korea (South)3
India2
Brazil2
Israel2
China2
New Zealand1
Singapore1
Italy1
Indonesia1
Colombia1
Germany1
Ecuador1
South Africa1
Viet Nam1
Spain1
Austria1
Croatia1

Where are Research Centers of Mitokinin Patents Located?

R&D Centres of Mitokinin

What Percentage of Mitokinin US Patent Applications Were Granted?

Mitokinin (Excluding its subsidiaries) has filed 5 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 4 have been granted leading to a grant rate of 80%.

Below are the key stats of Mitokinin patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Mitokinin?

Law FirmTotal ApplicationsSuccess Rate
Mintz Levin San Diego Office366.67%
Mitokinin2100%

What are Mitokinin key innovation segments?

What Technologies are Covered by Mitokinin?

The chart below distributes patents filed by Mitokinin in different countries on the basis of the technology protected in patents. It also represents the markets where Mitokinin thinks it’s important to protect particular technology inventions.

R&D Focus: How has Mitokinin search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Mitokinin?

Related Articles

Alphapharm Patents – Insights & Stats (Updated 2024)

Alphapharm has a total of 108 patents globally, out of which 43 have been granted. Of these 108 patents, more than 18% patents are active. Australia is where Alphapharm has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, Australia seems to be

Read More »

Complexa Patents – Insights & Stats (Updated 2024)

Complexa has a total of 77 patents globally, out of which 16 have been granted. Of these 77 patents, more than 22% patents are active. The United States of America is where Complexa has filed the maximum number of patents, followed by Japan. Parallelly, United States of America seems to

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.